Expanded Use Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Use Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Use Program Today - Breaking & Trending Today

Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update

Published: August 9, 2023

FDA indicated that approval of MAT2203 as a first-line treatment for invasive aspergillosis will require an adequately powered study with an active control group and an all-cause mortality...

Source: marketscreener.com

Related Topics:

United StatesNew JerseyJody CainMatinas BiopharmaJeromed JabbourNational Resilience IncNational ResilienceDevelopment AuthorityAccess ProgramEuropean CongressMatina Compassionate Expanded Use ProgramDrug AdministrationPopulation Pathway For AntifungalsOral Amphotericinb ProgramKey Program UpdatesMatinas Biopharma Holdings IncCompany Compassionate Expanded Use Access ProgramSmall Oligonucleotide ProgramBiomedical ResearchCompassionate Use ProgramExpanded Use ProgramNationwide ChildrenChief Executive OfficerLimited Population PathwayExpanded Use Access Program